← Open Payments lookup

MIKE LEDESMA: Open Payments

NPI 1306261599 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$782 in 44 payments from 16 companies in 2025. Trend: 2023 $1,713 · 2024 $1,622 · 2025 $782

Food & beverage: $782
CompanyPaymentsAmount
Novo Nordisk Inc16$234
ABBVIE INC.4$77
Otsuka America Pharmaceutical, Inc.3$70
Lilly USA, LLC2$57
Abbott Laboratories2$49
Amgen Inc.2$42
Boehringer Ingelheim Pharmaceuticals, Inc.2$39
PFIZER INC.2$37
SANOFI-AVENTIS U.S. LLC2$35
GlaxoSmithKline, LLC.2$29

Products named: Ozempic, REXULTI, JARDIANCE, Wegovy, VRAYLAR, FREESTYLE LIBRE 3, TZIELD, MOUNJARO.

Industry payments across TX — which companies pay providers there.